Journal
Nucleic acids research
Publication Date
10-28-2024
Volume
52
Issue
19
First Page
11536
Last Page
11551
Document Type
Open Access Publication
DOI
10.1093/nar/gkae761
Rights and Permissions
Jianfeng Chen, Siyuan Su, Adrian Pickar-Oliver, Anna M Chiarella, Quentin Hahn, Dennis Goldfarb, Erica W Cloer, George W Small, Smaran Sivashankar, Dale A Ramsden, Michael B Major, Nathaniel A Hathaway, Charles A Gersbach, Pengda Liu, Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency, Nucleic Acids Research, Volume 52, Issue 19, 28 October 2024, Pages 11536–11551, https://doi.org/10.1093/nar/gkae761. https://academic.oup.com/nar/article/52/19/11536/7748946?login=true. © The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Recommended Citation
Chen, Jianfeng; Su, Siyuan; Pickar-Oliver, Adrian; Chiarella, Anna M; Hahn, Quentin; Goldfarb, Dennis; Cloer, Erica W; Small, George W; Sivashankar, Smaran; Ramsden, Dale A; Major, Michael B; Hathaway, Nathaniel A; Gersbach, Charles A; and Liu, Pengda, "Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency." Nucleic acids research. 52, 19. 11536 - 11551. (2024).
https://digitalcommons.wustl.edu/oa_4/4444
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
